Philip Nickson
Consigliere Generale presso MONTE ROSA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Philip Nickson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Consigliere Generale | 01/03/2021 | - |
Storia della carriera di Philip Nickson
Precedenti posizioni note di Philip Nickson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2012 | 01/03/2021 |
Formazione di Philip Nickson
| Suffolk University | Graduate Degree |
| The University of Manchester | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 2 |
Posizioni
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Philip Nickson
- Esperienza
